Latest Capital Markets News

Page 8 of 128
Australian Unity Limited reported increased revenue for the half-year ending December 2025, but earnings declined sharply due to inflationary pressures and ongoing transformation investments. The company also completed a leadership transition and strengthened its balance sheet.
Claire Turing
Claire Turing
25 Feb 2026
NEXTDC has reported a robust first half of FY26, with strong revenue and earnings growth underpinned by a surging forward order book and expanded capital expenditure plans.
Sophie Babbage
Sophie Babbage
25 Feb 2026
Island Pharmaceuticals reports a 213.8% increase in half-year loss to $4.81 million, driven by strategic acquisition and clinical development investments. The company advances its antiviral portfolio with Galidesivir and ISLA-101, supported by strong US regulatory engagement and a $9 million capital raise.
Ada Torres
Ada Torres
25 Feb 2026
Anatara Lifesciences reports a significantly reduced net loss for H1 FY2026, driven by promising pre-clinical results in its anti-obesity program and a successful $1.2 million capital raise. The company also highlights positive Phase II trial outcomes for its gastrointestinal health product GaRP.
Ada Torres
Ada Torres
25 Feb 2026
Hiremii Limited has reported a record half-year revenue of $16.1 million, boosted by its acquisition of Prince Migration and advances in its AI recruitment platform. Despite a modest loss, the company is positioning itself for growth through technology innovation and strategic capital raises.
Sophie Babbage
Sophie Babbage
25 Feb 2026
Light & Wonder, Inc. reported robust full-year 2025 financial results, highlighted by record revenues, strong cash flow growth, and a major litigation settlement. The company also completed its transition to a sole ASX listing and returned $877 million to shareholders through share repurchases.
Victor Sage
Victor Sage
25 Feb 2026
Euroz Hartleys Group Limited reported a robust half-year result for December 2025, with net profit more than doubling to $13.84 million, driven by strong growth in equity capital markets and advisory fees.
Claire Turing
Claire Turing
24 Feb 2026
Thorney Technologies reported a sharply reduced half-year profit amid challenging market conditions but extended its share buyback to support shareholder value.
Victor Sage
Victor Sage
24 Feb 2026
Aspermont Limited has announced a significant security consolidation, reducing its ordinary shares on issue from nearly 2.91 billion to just over 11.6 million, aiming to streamline its capital structure and potentially enhance market liquidity.
Claire Turing
Claire Turing
24 Feb 2026
TrivarX Limited reported a $1.26 million half-year loss as it completed the acquisition of Stabl-Im brain imaging IP and validated its mental health screening technology in veterans. The company raised $4.2 million to fund clinical development and expand its diagnostic portfolio.
Ada Torres
Ada Torres
24 Feb 2026
QEM Limited confirms a $1.442 million capital raising via placement, addressing ASX queries on disclosure timing and compliance. The company clarifies board approvals and trading halt details, reinforcing its adherence to continuous disclosure obligations.
Maxwell Dee
Maxwell Dee
24 Feb 2026
OncoSil Medical has reported record dose sales and cash receipts in the first half of FY26, supported by encouraging clinical trial results and expanded European market penetration.
Ada Torres
Ada Torres
24 Feb 2026